Injectable “satellite livers” could offer an alternative to liver transplantation
The engineered tissue grafts could take on the liver’s function and help thousands of people with liver failure.
The engineered tissue grafts could take on the liver’s function and help thousands of people with liver failure.
By providing holistic information on a cell, an AI-driven method could help scientists better understand disease mechanisms and plan experiments.
In STS.059 (The Bioeconomy and Society), students explore the social and political factors at work in the biology, biotech, and biological engineering sectors.
Based on a virus-like particle built with a DNA scaffold, the approach could generate broadly neutralizing antibody responses against HIV or influenza.
The new system could be used at home or in doctors’ offices to scan people who are at high risk for breast cancer.
Founded by three MIT alumni, Gensaic uses AI-guided protein design to deliver RNA and other therapeutic molecules to specific cells or areas of the body.
Professor, mentor, and leader at MIT for more than 50 years shaped fundamental understandings of cell adhesion, the extracellular matrix, and molecular mechanisms of metastasis.
MIT engineers designed capsules with biodegradable radio frequency antennas that can reveal when the pill has been swallowed.
Nanoparticles coated with molecular sensors could be used to develop at-home tests for many types of cancer.
The MIT senior helps design proteins that spur the immune system to fight cancer and other diseases.
Therapeutic antibodies packaged into microparticles could be injected with a standard syringe, avoiding the need for lengthy and often uncomfortable infusions.
Temporarily anesthetizing the retina briefly reverts the activity of the visual system to that observed in early development and enables growth of responses to the amblyopic (“lazy”) eye.
Using a versatile problem-solving framework, researchers show how early relapse in lymphoma patients influences their chance for survival.
New findings may help researchers identify genetic mutations that contribute to rare diseases, by studying when and how single genes produce multiple versions of proteins.
MIT engineers show they can accurately measure blood glucose by shining near-infrared light on the skin.